Langland announces three new board appointments

Langland has announced the appointment of three new members of its board as it seeks to maintain its recent strong growth.

Alison Ferrucci has been promoted to the position of board member having originally joined the agency in 2001. During her time with the company, she has worked with clients such as GlaxoSmithKline, AstraZeneca, Bayer HealthCare and Abbott.

Her strong leadership qualities and knowledge of her clients and the business landscape as a whole saw her eventually become Langland's strategic delivery director last year.

In addition to Ms Ferrucci's promotion, global business director Kate Spencer has moved into the role of managing partner, while Andrew Spurgeon becomes an executive creative director.

Philip Chin, Langland's chief executive, said the appointments will "pave the way for future organisational development as we expand in scale and geographical reach to meet the needs of our clients".

This follows Langland's appointment of industry veteran Adrian Zambardino as its new director of planning earlier this month.